There was also a positive trend in the Composite SLE Responder Index of the ITT cohort.
← all excerpts
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study.
1
—
—
There was also a positive trend in the Composite SLE Responder Index of the ITT cohort.